Thieme E-Books & E-Journals -
Osteologie 2022; 31(03): 203
DOI: 10.1055/s-0042-1755912
Abstracts
Vorträge

Changes in dispensing of anti-osteoporotic drugs during COVID-19 pandemic

Authors

  • Theresa Stockinger

    1   Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Sigmund Freud University, School of medicine, Metabolic bone diseases, 1st Med. Department, Wien
  • Martina Behanova

    2   Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, Wien
  • Berthold Reichardt

    3   Austrian Social Health Insurance Fund, Österreichische Gesundheitskasse, Eisenstadt
  • Judith Haschka

    4   Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Med. Department, Wien
  • Heinrich Resch

    5   St. Vincent Hospital Vienna , Sigmund Freud University, School of medicine, Metabolic bone diseases, 2nd Department of Internal Medicine, Wien
  • Jochen Zwerina

    4   Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA Trauma Centre Meidling, 1st Med. Department, Wien
  • Roland Kocijan

    6   Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling, Sigmund Freud University, School of medicine, Metabolic bone diseases, 1st Med. Department, Wien